^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Mepact (mifamurtide)

    i
    Company:
    Medison, Takeda
    Drug class:
    Macrophage stimulant, Monocyte stimulant
    Related drugs:
    Apply
    Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study (Micros) (NCT03737435)
    Phase N/A
    Istituto Ortopedico Rizzoli
    Recruiting
    Last update posted :
    03/22/2024
    Initiation :
    12/12/2018
    Primary completion :
    06/30/2024
    Completion :
    06/30/2024
    PD-L1 • CD68
    |
    Mepact (mifamurtide)